Dabigatran Reversal with Idarucizumab
N Engl J Med
.
2017 Oct 26;377(17):1691-2.
doi: 10.1056/NEJMc1711337.
Authors
Charles V Pollack Jr
1
,
Paul A Reilly
2
,
Jeffrey I Weitz
3
Affiliations
1
Thomas Jefferson University, Philadelphia, PA charles.pollack@jefferson.edu
2
Boehringer Ingelheim, Ridgefield, CT
3
McMaster University, Hamilton, ON, Canada
PMID:
29069562
DOI:
10.1056/NEJMc1711337
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
Antithrombins*
Dabigatran*
Humans
Substances
Antibodies, Monoclonal, Humanized
Antithrombins
idarucizumab
Dabigatran